Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
STAR Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong price momentum
Analysts have been raising forward EPS estimates
High and improving ROE
Strong EPS growth and above median growth of industry
Low and declining Debt to Equity
Negative
Low revenue growth and lower than median growth of industry
Company's earnings are of low quality
Low dividend yield
Neutral
Moderate and stable operating margin
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
STAR Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
STAR Bulk, Block & Insider Trades
STAR Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Others
Demerger (DEM)"As part of Demerger each shareholder entitled to receive 1 common share of OneSource Specialty Pharma Ltd formerly known as Stelis Biopharma Limited for every 2 common shares held." Ex-date: 6th Dec 2024 Announced on: 25th Sep 2023
Demerger (DEM)"Scheme of arrangement between strides shasun limited sequent scientific limited and solara active pharma sciences limited." Ex-date: 6th Apr 2018 Announced on: 26th Mar 2018
MergerScheme of amalgamation with <STAR.NS> <STAR.NS> shall allot to the shareholders of <BDP.BO> one equity share for every twenty shares held by <BDP.BO>. Ex-date: 24th Dec 2001 Announced on: 11th Dec 2001
Company Profile
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa,... Read More
Key personnel
Mr. Arun Kumar PillaiD
Non-Executive Chairman of the Board
Mr. Badree KomandurD
Chief Executive Officer, Managing Director, Executive Director
Mr. Vikesh Kumar
Group Chief Financial Officer and Chief Investor Relations Officer
Mr. Ramaraju (Ram) Pvs
Chief Operating Officer
Ms. Surabhi Loshali
Group Chief Human Resources Officer
Ms. Manjula Ramamurthy
Compliance Officer, Company Secretary
Mr. Aditya Arun KumarD
Executive Director - Business Development
Mr. Umesh Kale
Chief of Quality Services
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Strides Pharma Science Ltd.?
The current share price of Strides Pharma Science Ltd. is ₹ 879.65 as of 05 Dec 2025.
What is the PE ratio of Strides Pharma Science Ltd.?
The Price-to-Earnings (PE) ratio of Strides Pharma Science Ltd. is 20.41 as of the latest financial data.
What is the ROE and ROCE of Strides Pharma Science Ltd.?
Strides Pharma Science Ltd. has a Return on Equity (ROE) of 15.81% and a Return on Capital Employed (ROCE) of 14.87% as per the latest financial reports.
What is the market cap of Strides Pharma Science Ltd.?
The market capitalization of Strides Pharma Science Ltd. stands at ₹ 8,108.00 Cr.
What is the dividend yield of Strides Pharma Science Ltd.?
The dividend yield of Strides Pharma Science Ltd. is 0.45% based on the current market price.
What is the RSI of Strides Pharma Science Ltd.?
The Relative Strength Index (RSI) of Strides Pharma Science Ltd. is 45.28.
What is the FII and DII holding in Strides Pharma Science Ltd.?
Foreign Institutional Investors (FII) hold 28.51% and Domestic Institutional Investors (DII) hold 11.43% of Strides Pharma Science Ltd. shares.
What sector does Strides Pharma Science Ltd. belong to?
Strides Pharma Science Ltd. operates in the Healthcare sector.
What is the beta of Strides Pharma Science Ltd. stock?
The beta of Strides Pharma Science Ltd. stock is 1.38, indicating its volatility relative to the broader market.
